Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-014697
Filing Date
2024-02-12
Accepted
2024-02-12 16:37:21
Documents
1
Group Members
MARK ANGELOYA GLOBAL INVESTMENTS II (U.S.), LPYA II GP, LPYAII GP II, LLCYORKVILLE ADVISORS GLOBAL II, LLCYORKVILLE ADVISORS GLOBAL, LP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm245685d2_sc13ga.htm SC 13G/A 124122
  Complete submission text file 0001104659-24-014697.txt   126100
Mailing Address 101 HUDSON STREET #3700 JERSEY CITY NJ 07302
Business Address 101 HUDSON STREET #3700 JERSEY CITY NJ 07302 201 985 8300
YA II PN, Ltd. (Filed by) CIK: 0001463928 (see all company filings)

EIN.: 980615492 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address THE CIRCLE 6 8058 ZURICH V8 CH-6370
Business Address THE CIRCLE 6 8058 ZURICH V8 CH-6370 41-41-618-80-00
NLS Pharmaceutics Ltd. (Subject) CIK: 0001783036 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92065 | Film No.: 24620619
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)